Scroll To Top
Health

FDA says experimental anti-HIV drug is effective

FDA says experimental anti-HIV drug is effective

Support The Advocate
We're asking for your help to continue our newsroom's important reporting. Support LGBTQ+ journalism by contributing today!

Boehringer Ingelheim's experimental anti-HIV drug is effective in some drug-resistant patients when used in combination with Abbott Laboratories' Norvir, U.S. regulatory staff said in documents released on Wednesday. Data for the Boehringer protease inhibitor, called Aptivus, previously known as tipranavir, "provide evidence of the additional antiviral effect over currently available antiretroviral regimens in a population which are 'heavily pretreated,' " Food and Drug Administration reviewers said. (Reuters)

30 Years of Out100Out / Advocate Magazine - Jonathan Groff & Wayne Brady

From our Sponsors

Most Popular

Latest Stories

Outtraveler Staff